Filing Flows

Filing Flows › Ardelyx (ARDX) › Q3 2026 › vs Q3 2025

Ardelyx (ARDX) Q3 2026 vs Q3 2025 (year over year)

Ardelyx's revenue rose $17.3M (+16%) from $110M in Q3 2025 to $128M in Q3 2026. The biggest changes: Product sales, net +$19.9M (+19%); Non-cash royalty revenue related to the sale of future royalties −$4.2M (-87%); Product supply revenue +$1.4M (—).

Ardelyx, Q3 2026: revenue $128M (+16% year over year), operating margin 3.2%, net loss $737K, operating cash flow $2.2M. The chart draws each line against Q3 2025, the increases inside each band.

Ardelyx: what changed, Q3 2026 vs Q3 2025Ardelyx: what changed, Q3 2026 vs Q3 2025Product sales, net$19.9MIBSRELA$18.1MOperating costs$18.0MCosts & expenses$17.1MSG&A$10.3MResearch & development$7.1MNon-cash royalty revenue rela…−$4.2MShare-based compensation$2.4MOperating cash sources$2.1MXPHOZAH$1.8M

Every line

LineQ3 2026Q3 2025Change%
IBSRELA$96.3M$78.2M$18.1M+23%
XPHOZAH$29.2M$27.4M$1.8M+7%
Product sales, net$125M$106M$19.9M+19%
Product supply revenue$1.4M$0$1.4M—
Non-cash royalty revenue related to the sale of future royalties$604K$4.8M−$4.2M-87%
Revenue$128M$110M$17.3M+16%
Net loss$737K$969K−$232K-24%
Costs & expenses$128M$111M$17.1M+15%
Operating costs$124M$106M$18.0M+17%
Interest & other, net$4.7M$5.5M−$865K-16%
Income tax$90K$102K−$12K-12%
Cost of revenue$4.5M$4.0M$557K+14%
Research & development$25.2M$18.1M$7.1M+39%
SG&A$93.9M$83.6M$10.3M+12%
Operating cash sources$15.7M$13.6M$2.1M+15%
Depreciation & amortization$621K$905K−$284K-31%
Share-based compensation$15.1M$12.7M$2.4M+19%
Net loss absorbed$737K$969K−$232K-24%
Working capital & other$12.8M$12.3M$501K+4%
Operating cash flow$2.2M$365K$1.8M+495%

Questions

How much did Ardelyx's revenue grow year over year in Q3 2026?

Ardelyx's revenue rose $17.3M (+16%) from $110M in Q3 2025 to $128M in Q3 2026.

What drove Ardelyx's revenue change in Q3 2026?

Product sales, net +$19.9M (+19%); Non-cash royalty revenue related to the sale of future royalties −$4.2M (-87%); Product supply revenue +$1.4M (—).

Q3 2026 results → · Compare in the interactive Sankey →